NDC Package 45802-263-37 Clindamycin Phosphate

Solution Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
45802-263-37
Package Description:
60 APPLICATOR in 1 JAR / 1 mL in 1 APPLICATOR
Product Code:
Proprietary Name:
Clindamycin Phosphate
Non-Proprietary Name:
Clindamycin Phosphate
Substance Name:
Clindamycin Phosphate
Usage Information:
This medication is used to treat acne. It helps to decrease the number of acne lesions. Clindamycin is an antibiotic which works by stopping the growth of bacteria.
11-Digit NDC Billing Format:
45802026337
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 797274 - clindamycin 1 % Medicated Pad
  • RxCUI: 797274 - clindamycin 10 MG/ML Medicated Pad
  • RxCUI: 797274 - clindamycin (as clindamycin phosphate) 10 MG/ML Medicated Pad
  • RxCUI: 797274 - clindamycin 1 % Topical Swab
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Padagis Israel Pharmaceuticals Ltd
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA065049
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    05-31-2006
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 45802-263-37?

    The NDC Packaged Code 45802-263-37 is assigned to a package of 60 applicator in 1 jar / 1 ml in 1 applicator of Clindamycin Phosphate, a human prescription drug labeled by Padagis Israel Pharmaceuticals Ltd. The product's dosage form is solution and is administered via topical form.

    Is NDC 45802-263 included in the NDC Directory?

    Yes, Clindamycin Phosphate with product code 45802-263 is active and included in the NDC Directory. The product was first marketed by Padagis Israel Pharmaceuticals Ltd on May 31, 2006 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 45802-263-37?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 45802-263-37?

    The 11-digit format is 45802026337. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-245802-263-375-4-245802-0263-37